U.S. flag

An official website of the United States government

  • delete

NM_001025603.2(RFX5):c.446G>A (p.Arg149Gln) AND MHC CLASS II DEFICIENCY 5

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 1, 2002
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004556040.1

Allele description

NM_001025603.2(RFX5):c.446G>A (p.Arg149Gln)

Gene:
RFX5:regulatory factor X5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_001025603.2(RFX5):c.446G>A (p.Arg149Gln)
HGVS:
  • NC_000001.11:g.151344444C>T
  • NG_007576.1:g.7850G>A
  • NM_000449.4:c.446G>A
  • NM_001025603.2:c.446G>AMANE SELECT
  • NM_001379412.1:c.446G>A
  • NM_001379413.1:c.446G>A
  • NM_001379414.1:c.446G>A
  • NM_001379415.1:c.446G>A
  • NM_001379416.1:c.446G>A
  • NM_001379417.1:c.446G>A
  • NM_001379418.1:c.446G>A
  • NM_001379419.1:c.326G>A
  • NM_001379420.1:c.326G>A
  • NP_000440.1:p.Arg149Gln
  • NP_000440.1:p.Arg149Gln
  • NP_001020774.1:p.Arg149Gln
  • NP_001366341.1:p.Arg149Gln
  • NP_001366342.1:p.Arg149Gln
  • NP_001366343.1:p.Arg149Gln
  • NP_001366344.1:p.Arg149Gln
  • NP_001366345.1:p.Arg149Gln
  • NP_001366346.1:p.Arg149Gln
  • NP_001366347.1:p.Arg149Gln
  • NP_001366348.1:p.Arg109Gln
  • NP_001366349.1:p.Arg109Gln
  • LRG_101t1:c.446G>A
  • LRG_101:g.7850G>A
  • LRG_101p1:p.Arg149Gln
  • NC_000001.10:g.151316920C>T
  • NM_000449.3:c.446G>A
  • P48382:p.Arg149Gln
Protein change:
R109Q; ARG149GLN
Links:
UniProtKB: P48382#VAR_015550; OMIM: 601863.0005; dbSNP: rs137853099
NCBI 1000 Genomes Browser:
rs137853099
Molecular consequence:
  • NM_000449.4:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001025603.2:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379412.1:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379413.1:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379414.1:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379415.1:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379416.1:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379417.1:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379418.1:c.446G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379419.1:c.326G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379420.1:c.326G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
MHC CLASS II DEFICIENCY 5 (MHC2D5)
Synonyms:
BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E
Identifiers:
OMIM: 620818

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000028292OMIM
no assertion criteria provided
Pathogenic
(Nov 1, 2002)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Brief report: twin boys with major histocompatibility complex class II deficiency but inducible immune responses.

Wolf HM, Hauber I, Gulle H, Thon V, Eggenbauer H, Fischer MB, Fiala S, Eibl MM.

N Engl J Med. 1995 Jan 12;332(2):86-90. No abstract available.

PubMed [citation]
PMID:
7990905

Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome.

Nekrep N, Jabrane-Ferrat N, Wolf HM, Eibl MM, Geyer M, Peterlin BM.

Nat Immunol. 2002 Nov;3(11):1075-81. Epub 2002 Sep 30.

PubMed [citation]
PMID:
12368908

Details of each submission

From OMIM, SCV000028292.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In cell lines (Ker) derived from a pair of Turkish twin brothers with MHC class II deficiency-5 (MHC2D5; 620818) originally reported by Wolf et al. (1995), Nekrep et al. (2002) identified a G-to-A transition at nucleotide 446 of the RFX5 gene, resulting in an arg149-to-gln (R149Q) mutation in the DNA-binding domain. In vitro functional expression studies showed that the mutant protein was unable to bind to the promoter of HLA-DRA (142860). In contrast to patients with other RFX5 mutations, the twin boys had a relatively mild phenotype.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 26, 2024